CI vs SOLV · P/E 2.4, rev $274.90B vs P/E 9.1, rev $8.25B
Cigna Corp (CI) versus Solventum Corp. (SOLV) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported SOLV revenue for 2024-12-31 was $8.25B. Net income was $479.0M. Revenue was up 0.7% from 2023-12-31 to 2024-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
CI currently screens at market cap $71.62B and trailing P/E 2.4. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
Not investment advice. Open the CI and SOLV stock pages for the full models.
Not investment advice.